300298.SZ Overview

Company Profile

Sinocare Inc. provides digital diabetes management products in the People's Republic of China. It offers blood and pressure products, multiparameter testing, and hospital and primary healthcare products; H102 Air, a hemoglobin monitoring system; and Safe AQ UA II, a uric acid monitoring system. The company also exports its products. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.

Related stocks

2697.HK

2697.HK • China

183 HKD

1.2B USD

2675.HK

2675.HK • China

33 HKD

1.64B USD

688198.SS

688198.SS • China

BEIJING BALANCE MEDICAL TECHNOL

69.83 CNY

1.44B USD 1Y -33.7%

688016.SS

688016.SS • China

SHANGHAI MICROPORT ENDOVASCULAR

84.9 CNY

1.57B USD 1Y -24.7%

300633.SZ

300633.SZ • China

19.34 CNY

1.23B USD 1Y -44.3%

600587.SS

600587.SS • China

SHINVA MEDICAL INSTRUMENT CO LT

13.12 CNY

1.19B USD 1Y -19.8%

600055.SS

600055.SS • China

BEIJING WANDONG MEDICAL TECHNOL

10.48 CNY

1.1B USD 1Y -41.3%

0853.HK

0853.HK • China

6.08 HKD

1.48B USD 1Y -59%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

5 Metrics

Country

Region

Sector

Industry

Medical Devices

Website

https://www.sinocare.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

42.8% p.a.

Max Drawdown (5Y)

-64.0%

Sharpe Ratio (5Y)

-0.24

Beta Factor

-0.15

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 64.2 (Elevated multiple compression risk)

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (42.8% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -72.1% in the extended horizon.